Biospace Med raises $18M

French digital radiography firm Biospace Med of Paris has raised $18 million to advance its market expansion in North America and Europe for its EOS ultralow-dose 2D/3D radiography system.

The company recently received clearance from the U.S. Food and Drug Administration (FDA) for EOS, which allows full-body 2D and 3D imaging of patients using less radiation dose than standard computed radiography x-ray.

Related Reading

FDA clears Biospace Med's sterEOS for pediatrics, March 11, 2010

Road to RSNA, Digital X-Ray, Biospace Med, October 22, 2008

FDA OKs 3D mode for Biospace Med's EOS, October 8, 2008

Biospace adds Latin American distributor, November 30, 2007

Biospace raises $18 million, November 27, 2007

Copyright © 2010 AuntMinnie.com

Page 1 of 1262
Next Page